William Brennan
Family Medicine · Pitman, NJNPI 1306884515
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 269 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,461 and has fallen 94.8% since, to $76 in 2025.
Across 269 payments — averaging $14.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$630
- Pfizer$503
- GSK$456
- AstraZeneca$317
- Amarin Pharma, Inc.$250
- AbbVie$233
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,802100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 53 | $630 |
| Pfizer | 41 | $503 |
| GSK | 36 | $456 |
| AstraZeneca | 18 | $317 |
| Amarin Pharma, Inc. | 19 | $250 |
| AbbVie(2 entities) | 21 | $233 |
| Amgen | 7 | $198 |
| Merck | 12 | $150 |
| Kowa Pharmaceuticals America, Inc. | 9 | $123 |
| Arbor Pharmaceuticals, Inc. | 8 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $101 |
| Boston Scientific | 2 | $88 |
| Astellas Pharma US Inc | 6 | $85 |
| Axsome Therapeutics, Inc. | 1 | $76 |
| Lilly USA, LLC | 5 | $71 |
| Stryker | 2 | $71 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $71 |
| Exact Sciences | 1 | $60 |
| Boehringer Ingelheim | 4 | $52 |
| Biohaven Pharmaceuticals, Inc. | 2 | $46 |
| Johnson & Johnson | 2 | $28 |
| Medtronic | 1 | $17 |
| Ironwood Pharmaceuticals, Inc | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $13 |
| Bausch Health US, LLC | 1 | $13 |
| Eyevance Pharmaceuticals LLC | 1 | $13 |
| Eisai Inc. | 1 | $13 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
How this compares
$3,809 in reported general payments places this provider in the 85th percentile of 2,084 family medicine providers in New Jersey.
Other family medicine in Pitman
- Mikhail VarshavskiChatham$1.4M
- Janet ColeFar Hills$466K
- Matthew PintoMarlton$239K
- Jennifer CaudleSewell$226K
- Jeffrey LevineNew Brunswick$195K
- Jennifer AmicoNew Brunswick$159K
- Dena LacaraFairfield$122K
- Gaurang BrahmbhattHoboken$89K
- Juan LatorreHoboken$71K
- Sally MravcakJersey City$64K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.